Related Experiment Videos
Presence of immunoreactive dynorphin in human cerebrospinal fluid
Abstract:
Immunoreactive dynorphin (I-dynorphin) was measured by radioimmunoassay in human cerebrospinal fluid (CSF). I-dynorphin concentration in CSF was 30 +/- 2 pg/ml. Sephadex G-25 column chromatography showed the main peak eluted at the position of dynorphin-(1-17). HPLC elution profile of this major peak from gel filtration showed a large peak corresponding to the position of dynorphin-(1-17) and small peaks corresponding to the positions of dynorphin-(1-13), dynorphin-(1-12) and other unknown peptides.
Insights
This study measured immunoreactive dynorphin (I-dynorphin) in human cerebrospinal fluid (CSF). The main form found in CSF was dynorphin-(1-17), indicating its significance in the central nervous system.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Dynorphin is a key endogenous opioid peptide.
- Understanding dynorphin's presence in human cerebrospinal fluid (CSF) is crucial for neurological research.
Purpose of the Study:
- To quantify immunoreactive dynorphin (I-dynorphin) levels in human CSF.
- To characterize the molecular forms of I-dynorphin present in human CSF.
Main Methods:
- Radioimmunoassay (RIA) was used to measure I-dynorphin concentration.
- Sephadex G-25 column chromatography and High-Performance Liquid Chromatography (HPLC) were employed for peptide characterization.
Main Results:
- The average concentration of I-dynorphin in human CSF was determined to be 30 +/- 2 pg/ml.
- Chromatographic analysis revealed that dynorphin-(1-17) is the predominant form of I-dynorphin in CSF.
- Smaller amounts of dynorphin-(1-13), dynorphin-(1-12), and other unidentified peptides were also detected.
Conclusions:
- Dynorphin-(1-17) is the primary circulating form of dynorphin in human cerebrospinal fluid.
- These findings contribute to the understanding of opioid peptide distribution in the central nervous system.